TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase I, open-label, randomized crossover trial is to investigate the
pharmacokinetic interaction between steady-state lopinavir/ritonavir and single-dose TMC207
in healthy volunteers.